This is the protocol for a review and there is no abstract. The objectives are as follows:, The primary objective is to assess the ability of sanchi agents to increase disability-free survival in patients with acute ischaemic stroke. The secondary objectives are to assess the effects of sanchi agents on neurological impairment and quality of life, and to determine any adverse reactions